Singapore Built Biomedical Research With Stem Cells U.S. Banned
This article was originally published in PharmAsia News
Executive Summary
Singapore's laws that make it easier to conduct research using embryonic stem cells are responsible for the nation building a biomedical research sector, a U.S. scientist said
|
Singapore's laws that make it easier to conduct research using embryonic stem cells are responsible for the nation building a biomedical research sector, a U.S. scientist said. In a speech in Singapore, Shu Chien, a biological scientist at the University of California, San Diego, said the United States only now has eased up on using the cells restricted in the past because they were controversial. Meanwhile, he said, Singapore is attracting some of the best minds in biomedical research because its laws enable the research, the speaker said. (Click here for more) "Liberal Laws Aid Biomedical Sector" - Straits Times (Singapore) (8/3/10) |